Matches in Nanopublications for { ?s ?p "[These results suggest a role for the FAAH 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[These results suggest a role for the FAAH 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results suggest a role for the FAAH 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results suggest a role for the FAAH 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP52648.RAcW21xmZKOfN06QdRk0pdcJcpo4lxtmErDFK1oKeuQBE130_assertion description "[These results suggest a role for the FAAH 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP52648.RAcW21xmZKOfN06QdRk0pdcJcpo4lxtmErDFK1oKeuQBE130_provenance.
- NP276542.RAFQm2hdXutmgwEd8PSRm478khvl-7Ciu3CMyKxHLfD6g130_assertion description "[These results suggest a role for the FAAH 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276542.RAFQm2hdXutmgwEd8PSRm478khvl-7Ciu3CMyKxHLfD6g130_provenance.
- NP488414.RAiYjzpZ3MK8qt5Brfq_VnLd--4sRUPyOqOUEmBFlhRyQ130_assertion description "[These results suggest a role for the FAAH 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488414.RAiYjzpZ3MK8qt5Brfq_VnLd--4sRUPyOqOUEmBFlhRyQ130_provenance.
- NP393002.RA6rieO0jwZLvWZzsS87eHiTx7waqlugKBpelSG-PB7sk130_assertion description "[These results suggest a role for the FAAH 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393002.RA6rieO0jwZLvWZzsS87eHiTx7waqlugKBpelSG-PB7sk130_provenance.
- NP91682.RA1JaXXYNLKuBNPSjvhBGbd1T8vpCvSIn4e51ovJfrjXc130_assertion description "[These results suggest a role for the FAAH 385 A/A missense polymorphism as an endocannabinoid risk factor in overweight/obesity and may provide indirect evidence to support cannabinoid antagonist treatment strategies in overweight disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91682.RA1JaXXYNLKuBNPSjvhBGbd1T8vpCvSIn4e51ovJfrjXc130_provenance.